This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Juvenile dermatomyositis
M13_JUVDERMATOMYO
juvenile dermatomyositis: Juvenile dermatomyositis (JDM) is the early-onset form of dermatomyositis (DM, see this term), a systemic, autoimmune inflammatory muscle disorder, characterized by proximal muscle weakness, evocative skin lesion, and systemic manifestations.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
44 |
4. Check minimum number of eventsNone |
44 |
5. Include endpointsNone |
44 |
6. Filter based on genotype QC (FinnGen only) |
44 |
Control definitions (FinnGen only)
- Control exclude
- M13_SYSTCONNECT
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- M33
- Name in latin
- Dermatomyositis juvenilis
Similar endpoints
↥List of similar endpoints to
Juvenile dermatomyositis
based on the number of shared cases.
Similar with more cases:
- Dermatopolymyositis
- Systemic connective tissue disorders
- Autoimmune diseases related-to ILD
- Autoimmune diseases
- Used for control exclusion in common control thyroid runs
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 274 | 169 | 105 |
| Only index persons | 232 | 146 | 86 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.00 | 0.00 | 0.00 |
| Only index persons | 0.00 | 0.01 | 0.00 |
| Median age at first event (years) | |||
| Whole population | - | 14.41 | 14.08 |
| Only index persons | 14.40 | 14.59 | 14.09 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 44 | 28 | 16 |
| Unadjusted period prevalence (%) | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | 23.00 | 13.58 | 39.47 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
No data
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
9
0
+∞
9.72
1.1
0.0
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
16
48
4.67
5.21
2.3
1.6
titre
560.0
448.0
—
9
10
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
9
10
10.94
5.05
2.1
1.0
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
7
6
13.52
4.44
1.9
1.0
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
16
63
3.42
3.43
11.0
3.7
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
6
7
9.67
3.37
1.5
1.0
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
7
11
7.32
3.32
1.3
1.4
g/l
0.2
0.2
—
7
11
(42870588) Differential panel, method unspecified - Blood
23
115
3.10
3.31
14.2
6.9
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
5
6
9.18
2.82
5.0
2.5
e9/l
4.8
5.5
—
5
6
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
5
6
9.18
2.82
5.4
2.8
%
62.4
60.5
—
5
6
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
11
38
3.53
2.82
6.8
3.8
u/l
249.0
226.9
0.45
11
38
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
15
71
2.69
2.24
2.0
2.4
mg/l
4.2
2.6
1.96
15
65
(3029937) Albumin [Presence] in Urine by Test strip
16
79
2.61
2.20
8.4
2.9
estimate
0.0
0.0
—
8
28
(3007853) Bacteria identified in Skin by Aerobe culture
10
41
2.86
1.91
1.2
1.6
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
23
145
2.23
1.79
3.0
3.2
ug/l
70.9
60.4
0.24
23
139
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
24
315
0.48
1.53
3.8
3.9
mmol/l
2.9
2.7
0.50
24
297
(3018095) Leukocytes [#/volume] in Urine
20
126
2.08
1.50
3.0
4.5
e6/l
4.5
24.6
2.05
15
94
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
24
314
0.48
1.50
3.9
3.6
mmol/l
4.5
4.6
0.12
24
297
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
5
16
3.38
1.48
1.2
1.3
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
24
313
0.49
1.46
3.9
3.5
mmol/l
1.3
1.5
1.75
24
294
(40758558) Short blood count panel - Blood
18
111
2.05
1.41
9.1
7.0
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
23
160
1.92
1.25
8.0
4.4
estimate
0.0
0.0
—
8
31
(3013512) EKG study
11
58
2.20
1.25
2.5
3.5
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
18
116
1.93
1.22
1.6
1.5
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
14
83
2.01
1.19
5.5
2.4
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
23
162
1.88
1.19
7.1
3.0
estimate
0.0
0.0
—
7
29
(3009261) Glucose [Presence] in Urine by Test strip
23
162
1.88
1.19
7.0
3.0
estimate
0.0
0.0
—
8
27
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
21
144
1.88
1.18
5.2
8.2
mmol/l
1.2
1.2
0.38
16
128
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
18
118
1.89
1.15
5.6
3.7
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
5
21
2.55
1.12
1.0
1.1
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
5
21
2.55
1.12
1.2
1.1
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
17
112
1.84
1.06
8.8
2.8
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
10
55
2.06
1.02
1.0
1.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
15
96
1.85
1.01
1.3
1.8
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
17
114
1.80
0.99
7.5
4.3
inr
1.4
1.1
—
9
29
(3022145) Colonoscopy Study observation
6
29
2.23
0.93
1.7
1.5
—
—
—
0
0
(3015736) pH of Urine
18
125
1.74
0.92
6.3
3.0
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
15
100
1.76
0.88
2.5
3.8
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
24
294
0.60
0.85
3.5
3.3
mmol/l
1.4
1.2
0.29
24
276
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
0
26
0.00
0.81
0.0
1.4
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
29
236
1.67
0.79
6.3
4.0
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
7
41
1.84
0.74
4.0
1.7
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
14
96
1.67
0.73
3.7
2.3
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
5
27
1.96
0.71
3.6
2.7
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
7
112
0.55
0.70
1.3
2.3
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
5
29
1.81
0.66
1.2
1.4
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
5
29
1.81
0.66
5.0
6.8
mmol/l
0.7
0.8
—
5
23
(3009508) Creatinine [Moles/volume] in Urine
5
88
0.51
0.64
5.4
4.0
mmol/l
4.3
8.4
—
5
81
(3000494) Fungus identified in Specimen by Culture
5
30
1.75
0.63
3.0
1.2
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
0
20
0.00
0.62
0.0
1.2
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
11
76
1.60
0.54
5.5
3.5
—
—
—
0
0
(3018418) pH of Serum or Plasma
12
85
1.57
0.54
4.4
2.9
ph
7.4
7.4
—
5
12
(36660697) Celiac disease serology panel - Serum
7
45
1.66
0.52
1.0
1.1
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
36
328
1.54
0.44
15.6
13.0
mmol/l
140.2
139.6
0.61
36
318
(3023103) Potassium [Moles/volume] in Serum or Plasma
36
329
1.52
0.44
15.9
13.0
mmol/l
3.9
3.9
0.30
36
316
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
0
15
0.00
0.42
0.0
1.5
—
1.1
—
0
15
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
0
15
0.00
0.42
0.0
1.7
—
2.9
—
0
9
(3028707) Methadone [Presence] in Urine by Screen method
0
16
0.00
0.42
0.0
1.3
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
0
16
0.00
0.42
0.0
9.4
—
0.6
—
0
16
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
26
293
0.72
0.39
4.2
4.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
10
74
1.45
0.36
2.3
2.1
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
15
121
1.36
0.34
1.5
2.0
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
14
115
1.32
0.28
1.7
1.8
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
9
75
1.25
0.27
1.7
3.6
umol/l
349.0
10288.1
—
9
68
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
6
81
0.70
0.27
1.5
1.5
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
7
93
0.71
0.25
1.7
1.9
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
15
126
1.29
0.25
5.9
3.6
u/l
29.5
28.1
0.18
15
119
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
5
37
1.40
0.24
3.8
13.3
mmol/l
25.4
24.5
—
5
37
(3014051) Protein [Presence] in Urine by Test strip
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
2.9
—
326.7
—
0
11
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.1
—
4.0
—
0
11
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.1
—
2.6
—
0
5
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
6
51
1.20
0.20
1.5
4.2
s
29.8
29.9
—
6
51
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
6
51
1.20
0.20
2.0
1.4
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
26
281
0.82
0.19
4.3
4.2
mmol/mol
42.0
38.0
0.98
26
268
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
8
68
1.22
0.18
1.5
1.5
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
38
362
1.36
0.17
17.3
10.2
—
—
—
0
0
(3044889) 12 lead EKG panel
19
210
0.83
0.17
3.9
2.9
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
10
84
1.25
0.15
2.4
2.2
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
11
125
0.84
0.12
1.9
1.9
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
7
83
0.81
0.08
11.3
3.1
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
18
173
1.07
0.02
5.8
3.9
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
34
341
0.99
0.00
17.2
14.2
%
40.2
39.9
0.11
22
280
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
31
315
0.95
0.00
5.5
4.7
mu/l
1.4
1.8
1.29
31
295
(3049717) Cytology report of Urine Cyto stain
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
98.4
—
0
7
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
5
57
0.86
0.00
1.2
1.6
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
33.3
—
0
7
(3033658) Prothrombin time (PT) actual/Normal
9
93
0.96
0.00
3.0
6.0
%
93.2
94.4
—
9
93
(3038177) Helicobacter pylori Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(4268621)
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
(4198724)
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
0
7
0.00
0.00
0.0
3.7
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(4146454)
0
5
0.00
0.00
0.0
3.4
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
5.0
—
0.6
—
0
5
(3039443) Prostate specific Ag panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
0
5
0.00
0.00
0.0
2.0
—
3.8
—
0
5
(3003694) ABO and Rh group [Type] in Blood
13
130
1.00
0.00
1.4
1.8
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
37
367
1.05
0.00
20.4
8.9
u/l
27.0
25.8
0.18
37
355
(3035933) Granulocytes/100 leukocytes in Blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006245) CD3-CD19+ cells/100 cells in Blood
0
5
0.00
0.00
0.0
2.0
—
9.8
—
0
5
(1617658) Protocol used for examination of sentinel lymph nodes
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
8
82
0.97
0.00
1.4
1.8
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
5
0.00
0.00
0.0
9.2
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
0
5
0.00
0.00
0.0
17.4
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.0
—
78.6
—
0
5
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.7
—
21.7
—
0
8
(3000093) Morphology [Interpretation] in Blood Narrative
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4094501)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
0
8
0.00
0.00
0.0
3.4
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
0
5
0.00
0.00
0.0
4.6
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.0
—
0.4
—
0
6
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
5
51
0.98
0.00
1.4
2.0
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
0
5
0.00
0.00
0.0
1.0
—
31.4
—
0
5
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
0
9
0.00
-0.00
0.0
1.3
—
107.7
—
0
9
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
0
9
0.00
-0.00
0.0
3.1
—
3.3
—
0
9
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
(4306422)
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint M13_JUVDERMATOMYO and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have M13_JUVDERMATOMYO.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: M13_JUVDERMATOMYO – Juvenile dermatomyositis
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data